- Home
- JWEL vs CELZ Comparison
JWEL vs CELZ Comparison
Compare JWEL & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWEL
- CELZ
- Stock Information
- Founded
- JWEL 2012
- CELZ 1998
- Country
- JWEL China
- CELZ United States
- Employees
- JWEL N/A
- CELZ N/A
- Industry
- JWEL Other Consumer Services
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- JWEL Consumer Discretionary
- CELZ Health Care
- Exchange
- JWEL Nasdaq
- CELZ Nasdaq
- Market Cap
- JWEL 4.1M
- CELZ 4.7M
- IPO Year
- JWEL 2021
- CELZ N/A
- Fundamental
- Price
- JWEL $2.43
- CELZ $2.27
- Analyst Decision
- JWEL
- CELZ
- Analyst Count
- JWEL 0
- CELZ 0
- Target Price
- JWEL N/A
- CELZ N/A
- AVG Volume (30 Days)
- JWEL 881.8K
- CELZ 23.0K
- Earning Date
- JWEL 12-27-2024
- CELZ 11-08-2024
- Dividend Yield
- JWEL N/A
- CELZ N/A
- EPS Growth
- JWEL N/A
- CELZ N/A
- EPS
- JWEL N/A
- CELZ N/A
- Revenue
- JWEL $160,009,293.00
- CELZ $11,000.00
- Revenue This Year
- JWEL N/A
- CELZ N/A
- Revenue Next Year
- JWEL N/A
- CELZ N/A
- P/E Ratio
- JWEL N/A
- CELZ N/A
- Revenue Growth
- JWEL N/A
- CELZ N/A
- 52 Week Low
- JWEL $1.00
- CELZ $2.12
- 52 Week High
- JWEL $3.71
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- JWEL 44.78
- CELZ 35.64
- Support Level
- JWEL $2.45
- CELZ $2.12
- Resistance Level
- JWEL $3.13
- CELZ $2.50
- Average True Range (ATR)
- JWEL 0.36
- CELZ 0.19
- MACD
- JWEL -0.11
- CELZ 0.02
- Stochastic Oscillator
- JWEL 3.67
- CELZ 26.55
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health and nutritional supplements, and household products e-commerce platform. It operates under Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing sales channels. The company's major merchandise categories are Cosmetic products, Health and nutritional supplements, and Household Products.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.